Dr. Jonathan Chou, MD, PhD

Dr. Chou practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Chou's NPI, 1245657311, was assigned on March 26, 2014. Dr. Chou graduated from University of California, San Francisco School of Medicine in 2014. Dr. Chou holds California license A141751.

Dr. Chou's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Chou's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Chou to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chou practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Chou's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chou is board certified in internal medicine by the American Board of Internal Medicine. Dr. Chou is licensed in California.

Dmand AI lists prostate cancer among the conditions Dr. Chou treats.

CMS data shows 433 Medicare services from Dr. Chou across 3 procedure codes in 2024, for 83 Medicare patients. Medicare paid $28,522 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 83 Medicare patients who saw Dr. Chou in 2024. The largest group is 75 to 84, with 42 patients. 75% of them have cancer, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chou's median patient age at 73, with 10% women.

In 2024, Dr. Chou wrote 130 Medicare Part D claims for 31 patients. 66% of them were for generic drugs. CMS names the drug for 44 of them, across 3 drugs with 11 or more claims each, at $294,080 in total drug cost. In 2023, CMS named 81 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Chou for performance year 2024, reported as part of a group. Dr. Chou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chou as offering telehealth.

Dmand AI links 95 papers to Dr. Chou, published from 2000 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Molecular Sequence Data, Kinetics and Amino Acid Sequence. Dr. Chou has published most often in J Biol Chem. Dr. Chou's most frequent co-authors are Rahul R. Aggarwal, MD, Terence Ware Friedlander, MS and Vadim S. Koshkin, MD.

CMS Open Payments shows 13 general payments to Dr. Chou from 2 drug and device companies from 2016 to 2019. Travel and lodging make up the largest share, 56% of the total. Sanofi and Genzyme US Companies paid the most, $1,041.

Dr. Chou graduated from University of California, San Francisco School of Medicine in 2014.

Dr. Chou is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.